Publications
Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
Maju Mathew Koola, Jennifer Sklar, Whitney Davis, Agnieszka Nikiforuk, John K Meissen, Aarti Sawant-Basak, Scott T Aaronson, Rouba Kozak
Schizophrenia research, S0920-9964(17)30406-1 10.1016/j.schres.2017.07.005
PMID:28705532
Tuesday, 11 July 2017
Schizophrenia research, S0920-9964(17)30406-1 10.1016/j.schres.2017.07.005
PMID:28705532
Tuesday, 11 July 2017
Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia.
Dariusz Zurawek, Anna Salerno-Kochan, Marta Dziedzicka-Wasylewska, Agnieszka Nikiforuk, Tomasz Kos, Piotr Popik
Schizophrenia research, S0920-9964(17)30201-3 10.1016/j.schres.2017.04.014
PMID:28433499
Thursday, 20 April 2017
Schizophrenia research, S0920-9964(17)30201-3 10.1016/j.schres.2017.04.014
PMID:28433499
Thursday, 20 April 2017
Comparison of pro-amnesic efficacy of scopolamine, biperiden, and phencyclidine by using passive avoidance task in CD-1 mice.
Natalia Malikowska, Kinga Sałat, Adrian Podkowa
Journal of pharmacological and toxicological methods, S1056-8719(16)30119-8 10.1016/j.vascn.2017.04.006
PMID:28412329
Thursday, 13 April 2017
Journal of pharmacological and toxicological methods, S1056-8719(16)30119-8 10.1016/j.vascn.2017.04.006
PMID:28412329
Thursday, 13 April 2017
Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile.
Vittorio Canale, Anna Partyka, Rafał Kurczab, Martyna Krawczyk, Tomasz Kos, Grzegorz Satała, Bartłomiej Kubica, Magdalena Jastrzębska-Więsek, Anna Wesołowska, Andrzej J Bojarski, Piotr Popik, Paweł Zajdel
Bioorganic & medicinal chemistry, S0968-0896(17)30359-0 10.1016/j.bmc.2017.03.057
PMID:28391970
Wednesday, 29 March 2017
Bioorganic & medicinal chemistry, S0968-0896(17)30359-0 10.1016/j.bmc.2017.03.057
PMID:28391970
Wednesday, 29 March 2017
Lesions of the Orbitofrontal but Not Medial Prefrontal Cortex Affect Cognitive Judgment Bias in Rats.
Joanna Golebiowska, Rafal Rygula
Frontiers in behavioral neuroscience, 10.3389/fnbeh.2017.00051
PMID:28377703
Tuesday, 21 March 2017
Frontiers in behavioral neuroscience, 10.3389/fnbeh.2017.00051
PMID:28377703
Tuesday, 21 March 2017
Effects of acute dopaminergic and serotonergic manipulations in the ACI paradigm depend on the basal valence of cognitive judgement bias in rats.
Joanna Golebiowska, Rafal Rygula
Behavioural brain research, S0166-4328(16)31261-X 10.1016/j.bbr.2017.02.013
PMID:28212943
Tuesday, 14 February 2017
Behavioural brain research, S0166-4328(16)31261-X 10.1016/j.bbr.2017.02.013
PMID:28212943
Tuesday, 14 February 2017
Effect of pregabalin on fear-based conditioned avoidance learning and spatial learning in a mouse model of scopolamine-induced amnesia.
Kinga Sałat, Adrian Podkowa, Natalia Malikowska, Jędrzej Trajer
Toxicology mechanisms and methods, 10.1080/15376516.2016.1273426
PMID:27996351
Sunday, 8 January 2017
Toxicology mechanisms and methods, 10.1080/15376516.2016.1273426
PMID:27996351
Sunday, 8 January 2017
Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
Agnieszka Potasiewicz, Agnieszka Nikiforuk, Małgorzata Hołuj, Piotr Popik
Journal of psychopharmacology (Oxford, England), 10.1177/0269881116675509
PMID:28168926
Tuesday, 15 November 2016
Journal of psychopharmacology (Oxford, England), 10.1177/0269881116675509
PMID:28168926
Tuesday, 15 November 2016
Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties.
Kinga Sałat, Adrian Podkowa, Natalia Malikowska, Felix Kern, Jörg Pabel, Ewelina Wojcieszak, Katarzyna Kulig, Klaus T Wanner, Beata Strach, Elżbieta Wyska
Neuropharmacology, S0028-3908(16)30473-7 10.1016/j.neuropharm.2016.10.019
PMID:27771379
Wednesday, 19 October 2016
Neuropharmacology, S0028-3908(16)30473-7 10.1016/j.neuropharm.2016.10.019
PMID:27771379
Wednesday, 19 October 2016
3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
Agnieszka Potasiewicz, Małgorzata Hołuj, Tomasz Kos, Piotr Popik, Hugo R Arias, Agnieszka Nikiforuk
Neuropharmacology, S0028-3908(16)30450-6 10.1016/j.neuropharm.2016.10.002
PMID:27717880
Tuesday, 4 October 2016
Neuropharmacology, S0028-3908(16)30450-6 10.1016/j.neuropharm.2016.10.002
PMID:27717880
Tuesday, 4 October 2016